Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Adjunctive active VNS was associated with greater suicidal ideation improvement than sham stimulation in patients with markedly treatment-resistant depression. The exploratory analysis was not powered as a confirmatory suicide-outcomes trial.
Psychiatric Pharmacy (BCPP) July 31st 2026
Multiple Sclerosis News Today
A network meta-analysis found that long-term vitamin D supplementation added to standard multiple sclerosis therapy was associated with reduced relapse risk and improved disability outcomes.
Endocrinology & Diabetes Nursing July 20th 2026
Healthline
Creatine supplementation showed mixed effects on depressive symptoms across five randomized trials involving patients with mood disorders. The early findings suggest potential adjunctive benefit in some populations but do not establish a consistent treatment effect.
Internal Medicine July 14th 2026
Medical News Today (MNT)
Emerging research suggests vitamin D may influence immune tolerance and gut interactions in IBD, though findings remain exploratory and adjunctive.
Ambulatory Care Nursing April 16th 2026
MDLinx
Oxytocin nasal spray shows promise as an adjunct therapy for acute loneliness, potentially improving patient engagement in the initial phases of psychotherapy.
Psychiatry July 17th 2024
Psychiatry Advisor
Among the approved SGAs for MDD, no single medication stands out as the first choice; decision-making is guided by individual patient profiles and side effect considerations.
Psychiatry May 7th 2024